Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|November 27, 2020
A review of the experience with pediatric written requests issued for oncology drug productsAlemayehu Y Akalu, Xi Meng, Gregory H Reaman, et al.
British Journal of Haematology|October 25, 2011
CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemiaHong Ma, Sanjive Qazi, Zahide Ozer, et al.
Cancer|May 24, 2014
Declining childhood and adolescent cancer mortalityMalcolm A Smith, Sean F Altekruse, Peter C Adamson, et al.
JAMA Oncology|January 4, 2024
Review of Racial and Ethnic Representation of Participants Enrolled in Pediatric Clinical Trials of Oncology Drugs Conducted Through FDA Written RequestsLola A Fashoyin-Aje, Alemayehu Y Akalu, Jessica Boehmer, et al.
Leukemia & Lymphoma|July 16, 2005
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology GroupDouglas P Olson, Barbara J Taylor, Mei La, et al.
Pediatric Blood & Cancer|August 11, 2006
A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group StudyPeter C Adamson, Katherine K Matthay, Michelle O'Brien, et al.
Cancer|October 5, 2002
Parental medication use and risk of childhood acute lymphoblastic leukemiaWanqing Wen, Xiao Ou Shu, John D Potter, et al.
Journal of the National Cancer Institute|April 30, 2021
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration PerspectiveMeena N Murugappan, Bellinda L King-Kallimanis, Gregory H Reaman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory SettingNavid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Neuro-Oncology|October 3, 2002
A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapyMark R Gilbert, Henry S Friedman, John F Kuttesch, et al.
Pageof 10